Form D · Biotechnology
Biogix, Inc.
El Segundo, CA · CIK 0001791046
Offering snapshot reported Oct 17, 2019 · SEC filing
- Reported sold
- $2M Offering amount: $2M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $2M Reported outside-investor minimum
- First sale
- Oct 17, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 17, 2019 | Initial | $2,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-351288
Source: Form D, filed Oct 17, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James Murphy | Director |
| Roman Trunin | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
201 Continental Boulevard Suite 230
El Segundo, CA, 90245
El Segundo, CA, 90245